chr22-19880695-A-G
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The ENST00000400521.7(TXNRD2):āc.1109T>Cā(p.Ile370Thr) variant causes a missense change. The variant allele was found at a frequency of 0.723 in 1,612,762 control chromosomes in the GnomAD database, including 426,057 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin ClinVar.
Frequency
Consequence
ENST00000400521.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TXNRD2 | NM_006440.5 | c.1109T>C | p.Ile370Thr | missense_variant | 13/18 | ENST00000400521.7 | NP_006431.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TXNRD2 | ENST00000400521.7 | c.1109T>C | p.Ile370Thr | missense_variant | 13/18 | 1 | NM_006440.5 | ENSP00000383365 | P4 |
Frequencies
GnomAD3 genomes AF: 0.766 AC: 116456AN: 152004Hom.: 45452 Cov.: 33
GnomAD3 exomes AF: 0.691 AC: 171567AN: 248132Hom.: 60644 AF XY: 0.689 AC XY: 93043AN XY: 135072
GnomAD4 exome AF: 0.719 AC: 1049835AN: 1460640Hom.: 380539 Cov.: 54 AF XY: 0.716 AC XY: 520024AN XY: 726630
GnomAD4 genome AF: 0.766 AC: 116583AN: 152122Hom.: 45518 Cov.: 33 AF XY: 0.758 AC XY: 56369AN XY: 74358
ClinVar
Submissions by phenotype
Glucocorticoid deficiency 5 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Dec 05, 2021 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Sep 09, 2016 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Primary dilated cardiomyopathy Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Cardiovascular phenotype Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 11, 2015 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at